Sterling Capital Management’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$20.9K Sell
1,577
-129
-8% -$1.63K ﹤0.01% 2172
2026
Q2
$18.9K Sell
1,706
-777
-31% -$4.75K ﹤0.01% 1909
2026
Q1
$19K Sell
2,483
-1,618
-39% -$12.4K ﹤0.01% 2054
2025
Q4
$39.9K Sell
4,101
-783
-16% -$6.66K ﹤0.01% 1887
2025
Q3
$20.5K Buy
4,884
+2,937
+151% +$18.8K ﹤0.01% 2127
2025
Q2
$18.1K Buy
1,947
+654
+51% +$5.71K ﹤0.01% 1828
2025
Q1
$12.6K Sell
1,293
-816
-39% -$10.1K ﹤0.01% 1792
2024
Q4
$25.5K Buy
2,109
+1,655
+365% +$20.1K ﹤0.01% 1802
2024
Q3
$4.98K Buy
+454
New +$4.61K ﹤0.01% 1765

Other funds holding REPL

Sterling Capital Management's REPL Position: Q3 2026 in Review

Sterling Capital Management reduced its Replimune Group (REPL) stake by 7.6% in Q3 2026, selling an estimated $1.63K and leaving 1,577 shares worth $20.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2172.

Sterling Capital Management first reported a position in REPL in Q3 2024 and has held it in 9 quarters since. The position peaked at $39.9K in Q4 2025. 78 funds tracked by Wall St. Rank hold REPL as of Q3 2026.

  • Sterling Capital Management held 1,577 shares of Replimune Group worth $20.9K as of Q3 2026.
  • Sterling Capital Management sold 129 Replimune Group shares in Q3 2026, an estimated $1.63K.
  • Replimune Group made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #2172 holding.
  • Sterling Capital Management first reported a position in Replimune Group in Q3 2024 and has held it in 9 quarters since.
  • Sterling Capital Management's Replimune Group position peaked at $39.9K in Q4 2025.
  • 78 funds tracked by Wall St. Rank held Replimune Group as of Q3 2026.

Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.